1-3 of 3
Mark Fesler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improvements in health-related quality of life (HRQoL) in the SUNMO study: Subcutaneous (SC) mosunetuzumab plus polatuzumab vedotin (Mosun-Pola) vs rituximab, gemcitabine and oxaliplatin (R-GemOx) in patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) after at least one prior therapy

Free
Elizabeth Budde, Jason Westin, Huilai Zhang, Dai Maruyama, Eduardo M. Rego, Huangming Hong, Hideki Goto, Mark Fesler, Boone Goodgame, Zhiming Li, Adam Olszewski, Joan Ashby, Shen Yin, Wahib S. Ead, Martin Janousek, Song Pham, Connie L. Batlevi, Michael C. Wei, Won-Seog Kim
Journal: Blood
Blood (2025) 146 (Supplement 1): 5509.
https://doi.org/10.1182/blood-2025-5509
Published: 2025
Journal Articles

Outpatient administration of epcoritamab monotherapy for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL): Results from EPCORE NHL-6 by race and ethnicity

Free
Adelba Torres, Rakhee Vaidya, Fernando Vargas Madueno, Sami Ibrahimi, Seema Naik, Mitul Gandhi, Julie Haydu, Bradley Lash, Mark Fesler, John Hrom, Eric Lee, Suchitra Sundaram, Kristin Conte, Kojo Osei-Bonsu, Yang Bai, Christian Eskelund, Alexander Boardman, Ralph Vincent Boccia, Christina Lee, David Andorsky, Jeff Sharman
Journal: Blood
Blood (2025) 146 (Supplement 1): 1959.
https://doi.org/10.1182/blood-2025-1959
Published: 2025
Journal Articles

Outcomes of Cytomegalovirus Monitoring in Autologous Transplantation: A Single Institution Experience

Free
Mark Fesler, Mackenzie J Poole, Linda Goldenberg, Alexis Guennette, Kara J Christopher
Journal: Blood
Blood (2021) 138 (Supplement 1): 3949.
https://doi.org/10.1182/blood-2021-147499
Published: 2021